Autoantibodies to topoisomerase I in a patient with systemic lupus erythematosus without features of scleroderma

Abstract

We report a woman with systemic lupus erythematosus (SLE) with diffuse proliferative glomerulonephritis and anti-dsDNA antibodies whose serum contained autoantibodies specific for the phosphorylated form of RNA polymerase II (RNAP IIO), Su and ribosomal P antigen, as well as anti-topoisomerase I antibodies, a marker for scleroderma (SSc). Over 6 years, the patient exhibited clinical manifestations consistent with SLE without clinical evidence of scleroderma. The reactivity of her serum autoantibodies with the phosphoproteins ribosomal P, topoisomerase I, and RNAP IIO is consistent with recognition of autoepitopes comprised in part of phosphate groups. This may explain the unexpected coexistence of marker autoantibodies for SLE and scleroderma, possibly with implications for the mechanisms of autoantibody generation.

Keywords

anti-topoisomerase I antibodies anti-RNA polymerase II antibodies anti-nuclear antibodies

Get full access to this article

View all access options for this article.

References

Tan EM Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol 1989; 44: 93-151.

Rothfield NF Autoantibodies in scleroderma. Rheum Dis Clin North Am 1992; 18: 483-498.

Kuwana M. et al. Autoantigenic epitopes on DNA topoisomerase I: clinical and immunogenetic associations in systemic sclerosis. Arthritis Rheum 1993; 36: 1406-1413.

Satoh M. et al. Association of autoantibodies to topoisomerase I and the phosphorylated (IIO) form of RNA polymerase II in Japanese scleroderma patients. J Immunol 1994; 153: 5838-5848.

Elkon KB , Bonfa E. , Brot N. Antiribosomal antibodies in systemic lupus erythematosus. Rheum Dis Clin North Am 1992; 18: 377-390.

Weiner ES et al. Prognostic significance of anti-centromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. Arthritis Rheum 1991; 34: 68-77.

Mukai S. et al. Three cases of anti-Scl-70 (topoisomerase I) antibody associated with central nervous system lupus without renal disorder. J Rheumatol 1993; 20: 1594-1597.

Satoh M. et al. Characterization of the Su antigen, a macromolecular complex of 100/102 and 200 KDa proteins recognized by autoantibodies in systemic rheumatic diseases. Clin Immunol Immunopathol 1994; 73: 132-141.

Satoh M. et al. Autoantibodies to RNA polymerase II are common in systemic lupus erythematosus and overlap syndrome. Specific recognition of the phosphorylated (IIO) form by a subset of human sera. J Clin Invest 1994; 94: 1981-1989.

10.

Hasler P. et al. The effect of phosphorylation and site-specific mutations in the immunodominant epitope of the human ribosomal P proteins. Clin Immunol Immunopathol 1994; 72: 273-279.